Key Record Dates Identifier: NCT01005979
Brief Title: A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Small Lymphocytic Lymphoma (SLL)

First Submitted : September 30, 2009
First Submitted that Met QC Criteria : October 30, 2009
First Posted : November 2, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : August 12, 2014
Last Update Posted : August 13, 2014 (Estimate)